Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...

Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...

Dr Mark Kris breaks down the lazertinib-amivantamab data, noting that the combo shows benefit but fails to address key ...

Despite a mismatch in the dominant strain and the flu vaccine this year, HCPs are still central in advising patients to receive shot, likely reducing severity of disease.

Chronic myeloid leukemia highlights from ASH 2025 include data on nilotinib vs imatinib, asciminib in second line, somatic ...

Insights from ASH 2025, including anticipated presentations, key takeaways, and how emerging research in paroxysmal nocturnal ...

When a parent’s health declines, doctors must navigate difficult, overlapping roles, balancing clinical knowledge with ...

In a 10-year study of postmenopausal women, tea consumption shows a small but significant benefit for bone mineral density, ...

Edward S. Cooper, MD, the American Heart Association’s first Black president, leaves behind an indelible mark on stroke ...

Growth hormone replacement therapy improves physical fitness, lifestyle habits, and quality of life in children with growth ...

Christmas traditions such as decorating a tree and singing not only lift spirits but also boost immunity by triggering immune ...

The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...